https://orcid.org/0009-0008-3084-3355
References
- Van Meurs JC. Relationship between peripheral vascular closure and proliferative retinopathy in sickle cell disease. Graefes Arch Clin Exp Ophthalmol. 1991;229(6):543–548. doi:10.1007/BF00203319
- Downes SM, Hambleton IR, Chuang EL, et al. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology. 2005;112:1869–1875. doi:10.1016/j.ophtha.2005.05.026
- Babalola OE, Wambebe CO. When should children and young adults with sickle cell disease be referred for eye assessment? Afr J Med Med Sci. 2001;30(4):261–263.
- Penman AD, Serjeant GR. Recent advances in the treatment of proliferative sickle cell retinopathy. Curr Opin Ophthalmol. 1992;3(3):379–388. doi:10.1097/00055735-199206000-00013
- Myint KT, Sahoo S, Thein AW, Moe S, Ni H. Laser therapy for retinopathy in sickle cell disease. Cochrane Database Syst Rev. 2015;2015(10):CD010790. doi:10.1002/14651858.CD010790.pub2
- Goldberg MF. Classification and pathogenesis of proliferative sickle cell retinopathy. Am J Ophthalmol. 1971;71(3):649–665. doi:10.1016/0002-9394(71)90429-6
- Children With Sickle Cell Disease Appear to Suffer Eye Complications at Same Rate as Adults, American Academy of Ophthalmology, Available from: https://www.aao.org/newsroom/news-releases/detail/children-with-sickle-cell-disease-appear-to-suffer. Accessed April 18, 2024.
- Pahl DA, Green NS, Bhatia M, Chen RWS. New ways to detect pediatric sickle cell retinopathy: a comprehensive review. J Pediatr Hematol Oncol. 2017;39(8):618–625. doi:10.1097/MPH.0000000000000919
- Li J, Bender L, Shaffer J, Cohen D, Ying GS, Binenbaum G. Prevalence and onset of pediatric sickle cell retinopathy. Ophthalmology. 2019;126(7):1000–1006. doi:10.1016/j.ophtha.2019.02.023